KRAS G12D inhibitor 15
KRAS G12D inhibitor 15 is a potent inhibitor of KRAS G12D. KRAS G12D inhibitor 15 has the potential for the research of various diseases or disorders, such as cancer or cancer metastasis (extracted from patent WO2022042630A1, compound 243) [1]. KRAS G12D inhibitor 15 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2763155-39-9
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12d-inhibitor-15.html
Solubility
10 mM in DMSO
Smiles
COC1=NC(C2=CC(O)=CC3=C2C(C#C)=C(F)C=C3)=C(F)C4=C1C(N5CC6NC(CC6)C5)=NC(OC[C@]78N(CCC8)[C@H](CC7)COC(N(C)CCCCCCCCCCCCCCCC)=O)=N4
Molecular Formula
C53H71F2N7O5
Molecular Weight
924.17
References & Citations
[1]Xing DAI, et al. Heteroaryl compounds, preparation methods and uses thereof. Patent WO2022042630A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF405S conjugate, 0.1mg/mL
